StockMap tracks 153 large-cap U.S. stocks in the Pharmaceuticals industry. Their combined market capitalisation is $4.03T. On the most recent trading day the industry was down 1.37% on average. Its largest constituents by market capitalisation are LLY, JNJ, MRK, NVS, AZN. Every stock in this industry carries a conviction signal and a two-week outlook, and calls that lean one way are graded in public once their window closes.
| Symbol | Name | Cap |
|---|---|---|
| LLY | Eli Lilly and Company | $1.33T |
| JNJ | Johnson & Johnson | $657.68B |
| MRK | Merck & Company Inc. Common Stock (new) | $368.89B |
| NVS | Novartis | $303.67B |
| AZN | AstraZeneca | $289.50B |
| PFE | Pfizer | $173.95B |
| NVO | Novo Nordisk A/S | $134.03B |
| BMY | Bristol-Myers Squibb Company | $127.71B |
| SNY | Sanofi ADS | $106.24B |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | $100.14B |
| TAK | Takeda Pharmaceutical Company | $66.81B |
| TEVA | Teva Pharmaceutical Industries | $49.05B |
| RPRX | Royalty Pharma | $38.63B |
| HLN | Haleon plc American Depositary Shares (Each representing two Ordinary Shares) | $38.09B |
| ZTS | Zoetis | $32.94B |
| VTRS | Viatris | $21.86B |
| JAZZ | Jazz Pharmaceuticals plc Common Stock (Ireland) | $14.02B |
| RDY | Dr. Reddy's Laboratories | $11.80B |
| ELAN | Elanco Animal Health Incorporated | $11.52B |
| CORT | Corcept Therapeutics Incorporated | $8.77B |
| AXSM | Axsome Therapeutics | $7.57B |
| AMRX | Amneal Pharmaceuticals | $7.49B |
| LGND | Ligand Pharmaceuticals Incorporated | $6.43B |
| BLTE | Belite Bio | $6.23B |
| MANE | Veradermics Incorporated | $5.84B |
| DFTX | Definium Therapeutics Inc. Common Shares | $4.88B |
| EWTX | Edgewise Therapeutics | $4.22B |
| INDV | Indivior Pharmaceuticals | $4.17B |
| LQDA | Liquidia | $4.03B |
| TARS | Tarsus Pharmaceuticals | $3.66B |
| OGN | Organon & Co | $3.63B |
| AMLX | Amylyx Pharmaceuticals | $3.62B |
| RGC | Regencell Bioscience Holdings | $3.33B |
| ELVN | Enliven Therapeutics | $3.24B |
| BHC | Bausch Health Companies | $3.07B |
| MBX | MBX Biosciences | $2.69B |
| SUPN | Supernus Pharmaceuticals | $2.44B |
| PHVS | Pharvaris | $2.35B |
| PBH | Prestige Consumer Healthcare | $2.32B |
| HCM | HUTCHMED (China) | $2.29B |
| HRMY | Harmony Biosciences Holdings | $2.26B |
| PRGO | Perrigo Company | $2.19B |
| SEPN | Septerna | $2.05B |
| TRLV | Trulieve Cannabis Corp. Subordinate Voting Shares | $1.98B |
| XERS | Xeris Biopharma Holdings | $1.95B |
| TRVI | Trevi Therapeutics | $1.93B |
| MAZE | Maze Therapeutics | $1.70B |
| NUVB | Nuvation Bio | $1.67B |
| ANIP | ANI Pharmaceuticals | $1.65B |
| PAHC | Phibro Animal Health | $1.58B |
| INVA | Innoviva | $1.53B |
| OCUL | Ocular Therapeutix | $1.53B |
| ETON | Eton Pharmaceuticals | $1.49B |
| PCRX | Pacira BioSciences | $1.45B |
| RAPP | Rapport Therapeutics | $1.45B |
| GHRS | GH Research | $1.43B |
| OMER | Omeros | $1.33B |
| KARD | Kardigan | $1.32B |
| LBRX | LB Pharmaceuticals | $1.28B |
| CRON | Cronos Group Inc. Common Share | $1.22B |
| AMPH | Amphastar Pharmaceuticals | $1.18B |
| AVLN | Avalyn Pharma | $1.14B |
| SGP | SpyGlass Pharma | $1.08B |
| HROW | Harrow | $1.06B |
| SPTX | Seaport Therapeutics | $1.05B |
| ANRO | Alto Neuroscience | $886.87M |
| ALMS | Alumis | $871.10M |
| HELP | Helus Pharma | $843.28M |
| COLL | Collegium Pharmaceutical | $774.83M |
| WVE | Wave Life Sciences | $708.05M |
| LXRX | Lexicon Pharmaceuticals | $631.84M |
| ZVRA | Zevra Therapeutics | $610.47M |
| ACRS | Aclaris Therapeutics | $586.01M |
| ARVN | Arvinas | $513.93M |
| OCS | Oculis Holding AG Ordinary shares | $509.91M |
| AQST | Aquestive Therapeutics | $488.24M |
| EOLS | Evolus | $485.47M |
| PHAT | Phathom Pharmaceuticals | $466.62M |
| CRMD | CorMedix | $443.89M |
| RLMD | Relmada Therapeutics | $381.88M |
| TLRY | Tilray Brands | $373.90M |
| AGMB | AgomAb Therapeutics NV | $368.87M |
| CTNM | Contineum Therapeutics | $353.26M |
| AVIR | Atea Pharmaceuticals | $329.64M |
| TTRX | Turn Therapeutics | $318.46M |
| VFF | Village Farms International Inc. Common Shares | $305.71M |
| SNDL | SNDL Inc. Common Shares | $301.69M |
| FULC | Fulcrum Therapeutics | $283.06M |
| CGC | Canopy Growth Corporation Common Shares | $276.24M |
| BIOA | BioAge Labs | $269.42M |
| ACB | Aurora Cannabis Inc. Common Shares | $263.26M |
| SLGL | Sol-Gel Technologies | $223.78M |
| SIGA | SIGA Technologies | $218.42M |
| MDWD | MediWound | $171.70M |
| ORMP | Oramed Pharmaceuticals | $170.96M |
| ANTX | AN2 Therapeutics | $170.94M |
| NGEN | NervGen Pharma Corp. Common stock | $147.43M |
| OGI | Organigram Global Inc. Common Shares | $131.57M |
| DERM | Journey Medical | $114.90M |
| PYPD | PolyPid | $109.48M |
| NRXP | NRX Pharmaceuticals | $98.28M |
| LENZ | LENZ Therapeutics | $95.83M |
| NTHI | NeOnc Technologies Holdings | $93.90M |
| MIST | Milestone Pharmaceuticals Inc. Common Shares | $90.88M |
| PLYX | Polaryx Therapeutics | $87.23M |
| NTRB | Nutriband | $76.58M |
| CING | Cingulate | $72.42M |
| CPIX | Cumberland Pharmaceuticals | $70.27M |
| VRCA | Verrica Pharmaceuticals | $57.55M |
| RFL | Rafael Holdings | $56.36M |
| ELOX | Eloxx Pharmaceuticals | $54.28M |
| PLRX | Pliant Therapeutics | $53.18M |
| HYPD | Hyperion DeFi | $48.95M |
| LONA | LeonaBio | $46.54M |
| GRCE | Grace Therapeutics | $40.81M |
| SCYX | SCYNEXIS | $37.51M |
| VERU | Veru | $37.34M |
| NSRX | Nasus Pharma | $35.96M |
| IXHL | Incannex Healthcare | $31.61M |
| EYPT | EyePoint | $30.04M |
| AARD | Aardvark Therapeutics | $29.76M |
| CPHI | China Pharma Holdings | $26.88M |
| AYTU | Aytu BioPharma | $20.98M |
| TXMD | TherapeuticsMD | $20.83M |
| QNTM | Quantum Biopharma Ltd. Class B Subordinate Voting Shares | $19.59M |
| COCP | Cocrystal Pharma | $19.17M |
| SCLX | Scilex Holding Company | $15.71M |
| CTXR | Citius Pharmaceuticals | $14.36M |
| DARE | Dare Bioscience | $13.76M |
| LPCN | Lipocine | $11.87M |
| ASBP | Aspire-Lakewood Holdings | $11.38M |
| TVRD | Tvardi Therapeutics | $10.58M |
| INM | InMed Pharmaceuticals Inc. Common Shares | $8.79M |
| UPC | Universe Pharmaceuticals | $7.49M |
| LEXX | Lexaria Bioscience | $7.35M |
| CNSP | CNS Pharmaceuticals | $7.30M |
| ENVB | Enveric Biosciences | $6.40M |
| SNES | SenesTech | $5.86M |
| PCSA | Processa Pharmaceuticals | $5.29M |
| SNOA | Sonoma Pharmaceuticals | $5.27M |
| PULM | Pulmatrix | $5.11M |
| YCBD | cbdMD | $4.29M |
| QCLS | Q/C Technologies | $3.56M |
| CVKD | Cadrenal Therapeutics | $3.51M |
| RDHL | Redhill Biopharma | $3.45M |
| ADXN | Addex Therapeutics | $3.28M |
| SXTC | China SXT Pharmaceuticals | $2.23M |
| PRFX | PRF Technologies | $2.22M |
| PPBT | Purple Biotech | $1.90M |
| SPRC | SciSparc | $1.39M |
| ARTL | Artelo Biosciences | $1.22M |
| AKAN | Akanda Corp. Common Shares | $562,640 |
| JAGX | Jaguar Health |
The two-week call for each stock is on its stock page.
Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 2, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.